Literature DB >> 26131734

Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa.

Tania M Gonzalez Santiago1, Andrey Zavialov2, Janna Saarela3, Mikko Seppanen4, Ann M Reed5, Roshini S Abraham6, Lawrence E Gibson1.   

Abstract

IMPORTANCE: Mutations in the CERC1 gene associated with deficiency in the ADA2 protein (DADA2) have been implicated in the pathogenesis of cutaneous polyarteritis nodosa (cPAN) and early-onset vasculopathy. DADA2 is not only limited to cPAN and vasculopathy but also includes immunodeficiency that affects several cellular compartments, including B cells; however, some patients appear to have a more indolent, skin-limited disease. OBSERVATIONS: In this report, we describe 2 white siblings (female and male) with a history of cPAN with DADA2 as a result of novel compound heterozygous mutations inherited in trans in the CECR1 gene (c.37_39del [p.K13del] and c.1159C>A [p.N328K]). The onset of disease was earlier in the female sibling than the male sibling although both were diagnosed as having cPAN in early childhood. The disease is associated with a more significant immunodeficiency and other systemic symptoms in the female than the male sibling. CONCLUSIONS AND RELEVANCE: These findings suggest a genetic cause of cPAN in some patients. Therefore, DADA2 should be considered in patients with cPAN, specifically in those whose conditions are diagnosed at an early age, regardless of their ethnicity, presence or absence of systemic symptoms, or a family history of the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26131734     DOI: 10.1001/jamadermatol.2015.1635

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  30 in total

1.  [Update: polyarteritis nodosa].

Authors:  Jan H Schirmer; Frank Moosig
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

2.  A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.

Authors:  Mélanie Rama; Claire Duflos; Isabelle Melki; Didier Bessis; Axelle Bonhomme; Hélène Martin; Diane Doummar; Stéphanie Valence; Diana Rodriguez; Emilie Carme; David Genevieve; Ketil Heimdal; Antonella Insalaco; Nathalie Franck; Viviane Queyrel-Moranne; Nathalie Tieulie; Jonathan London; Florence Uettwiller; Sophie Georgin-Lavialle; Alexandre Belot; Isabelle Koné-Paut; Véronique Hentgen; Guilaine Boursier; Isabelle Touitou; Guillaume Sarrabay
Journal:  Eur J Hum Genet       Date:  2018-04-23       Impact factor: 4.246

3.  A Chinese DADA2 patient: report of two novel mutations and successful HSCT.

Authors:  Luyao Liu; Wenjie Wang; Ying Wang; Jia Hou; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Danru Liu; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  Immunogenetics       Date:  2019-01-05       Impact factor: 2.846

4.  Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias.

Authors:  Abhishek A Mangaonkar; Alejandro Ferrer; Filippo Pinto E Vairo; Margot A Cousin; Ryan J Kuisle; Naseema Gangat; William J Hogan; Mark R Litzow; Tammy M McAllister; Eric W Klee; Konstantinos N Lazaridis; A Keith Stewart; Mrinal M Patnaik
Journal:  Mayo Clin Proc       Date:  2019-06-27       Impact factor: 7.616

5.  Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.

Authors:  Sezgin Sahin; Amra Adrovic; Kenan Barut; Serdal Ugurlu; Eda Tahir Turanli; Huri Ozdogan; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2017-05-17       Impact factor: 2.631

6.  Early-onset stroke, polyarteritis nodosa (PAN), and livedo racemosa.

Authors:  Dominique C Pichard; Amanda K Ombrello; Patrycja Hoffmann; Deborah L Stone; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2016-08       Impact factor: 11.527

7.  Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.

Authors:  Amy P Hsu; Robert R West; Katherine R Calvo; Jennifer Cuellar-Rodriguez; Mark Parta; Susan J Kelly; Nancy J Ganson; Michael S Hershfield; Steven M Holland; Dennis D Hickstein
Journal:  J Allergy Clin Immunol       Date:  2016-04-06       Impact factor: 10.793

Review 8.  Diagnostic approach and current treatment options in childhood vasculitis.

Authors:  Kenan Barut; Sezgin Şahin; Amra Adroviç; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2015-12-01

Review 9.  Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.

Authors:  Hasan Hashem; Susan J Kelly; Nancy J Ganson; Michael S Hershfield
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.592

10.  Impact of integrated translational research on clinical exome sequencing.

Authors:  Margot A Cousin; Filippo Pinto E Vairo; Joel A Morales-Rosado; Erica L Macke; Eric W Klee; W Garrett Jenkinson; Alejandro Ferrer; Laura E Schultz-Rogers; Rory J Olson; Gavin R Oliver; Ashley N Sigafoos; Tanya L Schwab; Michael T Zimmermann; Raul A Urrutia; Charu Kaiwar; Aditi Gupta; Patrick R Blackburn; Nicole J Boczek; Carri A Prochnow; Rebecca J Lowy; Lindsay A Mulvihill; Tammy M McAllister; Stacy L Aoudia; Teresa M Kruisselbrink; Lauren B Gunderson; Jennifer L Kemppainen; Laura J Fisher; Jessica M Tarnowski; Megan M Hager; Sarah A Kroc; Nicole L Bertsch; Katherine E Agre; Jessica L Jackson; Sarah K Macklin-Mantia; Marine I Murphree; Laura M Rust; Jolene M Summer Bolster; Scott A Beck; Paldeep S Atwal; Marissa S Ellingson; Sarah S Barnett; Kristen J Rasmussen; Carrie A Lahner; Zhiyv Niu; Linda Hasadsri; Matthew J Ferber; Cherisse A Marcou; Karl J Clark; Pavel N Pichurin; David R Deyle; Eva Morava-Kozicz; Ralitza H Gavrilova; Radhika Dhamija; Klaas J Wierenga; Brendan C Lanpher; Dusica Babovic-Vuksanovic; Gianrico Farrugia; Lisa A Schimmenti; A Keith Stewart; Konstantinos N Lazaridis
Journal:  Genet Med       Date:  2020-11-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.